Depression Drugs Market in US - Industry Outlook and Forecast 2020-2026

Publisher Name :
Date: 28-May-2020
No. of pages: 100

Depression is a mental health issue. It's a condition that starts most often in early adulthood. It's also more common in women. However, anyone at any age may suffer from depression. Depression affects the brain, so drugs that work in the brain may offer hope. Common antidepressants may help ease your symptoms, but there are many other options as well. Each drug used to treat depression works by balancing certain chemicals in your brain called neurotransmitters. Depression Drugs is drugs used for Depression.

This report contains market size and forecasts of Depression Drugs in US, including the following market information:

US Depression Drugs Market Revenue, 2015-2020, 2021-2026, ($ millions)

Top Five Competitors in US Depression Drugs Market 2019 (%)

The global Depression Drugs market was valued at 16380 million in 2019 and is projected to reach US$ 18280 million by 2026, at a CAGR of 2.8% during the forecast period. While the Depression Drugs market size in US was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.

COVID-19 pandemic has big impact on Depression Drugs businesses, with lots of challenges and uncertainty faced by many players of Depression Drugs in US. This report also analyses and evaluates the COVID-19 impact on Depression Drugs market size in 2020 and the next few years in US

Total Market by Segment:

US Depression Drugs Market, By Type, 2015-2020, 2021-2026 ($ millions)

US Depression Drugs Market Segment Percentages, By Type, 2019 (%)

- SSRIs

- SNRIs

- Others

US Depression Drugs Market, By Application, 2015-2020, 2021-2026 ($ millions)

US Depression Drugs Market Segment Percentages, By Application, 2019 (%)

- Hospitals

- Clinics

- Others

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Depression Drugs Market Competitors Revenues in US, by Players 2015-2020 (Estimated), ($ millions)

Total Depression Drugs Market Competitors Revenues Share in US, by Players 2019 (%)

Further, the report presents profiles of competitors in the market, including the following:

- Intellipharmaceutics

- Pfizer

- Eli Lilly

- Astrazeneca

- Lundbeck

- Allergan

- GSK

- Otsuka Pharmaceutical

- Takeda

- NHU Group

- Shionogi

- APOTEX

- Kanghong Pharma

Depression Drugs Market in US - Industry Outlook and Forecast 2020-2026

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Depression Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 COVID-19 Impact: US Depression Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats

2 US Depression Drugs Overall Market Size
2.1 US Depression Drugs Market Size: 2020 VS 2026
2.2 US Depression Drugs Revenue, Prospects & Forecasts: 2015-2026

3 Company Landscape
3.1 Top Depression Drugs Players in US (including Foreign and Local Companies)
3.2 Top US Depression Drugs Companies Ranked by Revenue
3.3 US Depression Drugs Revenue by Companies (including Foreign and Local Companies)
3.4 Top 3 and Top 5 Depression Drugs Companies in US, by Revenue in 2019
3.5 US Manufacturers Depression Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Depression Drugs Players in US
3.6.1 List of US Tier 1 Depression Drugs Companies
3.6.2 List of US Tier 2 and Tier 3 Depression Drugs Companies

4 Sights by Product
4.1 Overview
4.1.1 By Type - US Depression Drugs Market Size Markets, 2020 & 2026
4.1.2 SSRIs
4.1.3 SNRIs
4.1.4 Others
4.2 By Type - US Depression Drugs Revenue & Forecasts
4.2.1 By Type - US Depression Drugs Revenue, 2015-2020
4.2.2 By Type - US Depression Drugs Revenue, 2021-2026
4.2.3 By Type - US Depression Drugs Revenue Market Share, 2015-2026
5 Sights by Application
5.1 Overview
5.1.1 By Application - US Depression Drugs Market Size, 2020 & 2026
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - US Depression Drugs Revenue & Forecasts
5.2.1 By Application - US Depression Drugs Revenue, 2015-2020
5.2.2 By Application - US Depression Drugs Revenue, 2021-2026
5.2.3 By Application - US Depression Drugs Revenue Market Share, 2015-2026
6 Players Profiles
6.1 Intellipharmaceutics
6.1.1 Intellipharmaceutics Corporate Summary
6.1.2 Intellipharmaceutics Business Overview
6.1.3 Intellipharmaceutics Depression Drugs Major Product Offerings
6.1.4 Intellipharmaceutics Revenue in US (2015-2020)
6.1.5 Intellipharmaceutics Key News
6.2 Pfizer
6.2.1 Pfizer Corporate Summary
6.2.2 Pfizer Business Overview
6.2.3 Pfizer Depression Drugs Major Product Offerings
6.2.4 Pfizer Revenue in US (2015-2020)
6.2.5 Pfizer Key News
6.3 Eli Lilly
6.3.1 Eli Lilly Corporate Summary
6.3.2 Eli Lilly Business Overview
6.3.3 Eli Lilly Depression Drugs Major Product Offerings
6.3.4 Eli Lilly Revenue in US (2015-2020)
6.3.5 Eli Lilly Key News
6.4 Astrazeneca
6.4.1 Astrazeneca Corporate Summary
6.4.2 Astrazeneca Business Overview
6.4.3 Astrazeneca Depression Drugs Major Product Offerings
6.4.4 Astrazeneca Revenue in US (2015-2020)
6.4.5 Astrazeneca Key News
6.5 Lundbeck
6.5.1 Lundbeck Corporate Summary
6.5.2 Lundbeck Business Overview
6.5.3 Lundbeck Depression Drugs Major Product Offerings
6.5.4 Lundbeck Revenue in US (2015-2020)
6.5.5 Lundbeck Key News
6.6 Allergan
6.6.1 Allergan Corporate Summary
6.6.2 Allergan Business Overview
6.6.3 Allergan Depression Drugs Major Product Offerings
6.6.4 Allergan Revenue in US (2015-2020)
6.6.5 Allergan Key News
6.7 GSK
6.6.1 GSK Corporate Summary
6.6.2 GSK Business Overview
6.6.3 GSK Depression Drugs Major Product Offerings
6.4.4 GSK Revenue in US (2015-2020)
6.7.5 GSK Key News
6.8 Otsuka Pharmaceutical
6.8.1 Otsuka Pharmaceutical Corporate Summary
6.8.2 Otsuka Pharmaceutical Business Overview
6.8.3 Otsuka Pharmaceutical Depression Drugs Major Product Offerings
6.8.4 Otsuka Pharmaceutical Revenue in US (2015-2020)
6.8.5 Otsuka Pharmaceutical Key News
6.9 Takeda
6.9.1 Takeda Corporate Summary
6.9.2 Takeda Business Overview
6.9.3 Takeda Depression Drugs Major Product Offerings
6.9.4 Takeda Revenue in US (2015-2020)
6.9.5 Takeda Key News
6.10 NHU Group
6.10.1 NHU Group Corporate Summary
6.10.2 NHU Group Business Overview
6.10.3 NHU Group Depression Drugs Major Product Offerings
6.10.4 NHU Group Revenue in US (2015-2020)
6.10.5 NHU Group Key News
6.11 Shionogi
6.11.1 Shionogi Corporate Summary
6.11.2 Shionogi Depression Drugs Business Overview
6.11.3 Shionogi Depression Drugs Major Product Offerings
6.11.4 Shionogi Revenue in US (2015-2020)
6.11.5 Shionogi Key News
6.12 APOTEX
6.12.1 APOTEX Corporate Summary
6.12.2 APOTEX Depression Drugs Business Overview
6.12.3 APOTEX Depression Drugs Major Product Offerings
6.12.4 APOTEX Revenue in US (2015-2020)
6.12.5 APOTEX Key News
6.13 Kanghong Pharma
6.13.1 Kanghong Pharma Corporate Summary
6.13.2 Kanghong Pharma Depression Drugs Business Overview
6.13.3 Kanghong Pharma Depression Drugs Major Product Offerings
6.13.4 Kanghong Pharma Revenue in US (2015-2020)
6.13.5 Kanghong Pharma Key News
6.14 HUAHAI
6.14.1 HUAHAI Corporate Summary
6.14.2 HUAHAI Depression Drugs Business Overview
6.14.3 HUAHAI Depression Drugs Major Product Offerings
6.14.4 HUAHAI Revenue in US (2015-2020)
6.14.5 HUAHAI Key News

7 Key Market Trends & Influences 2021-2026
7.1 PESTLE Analysis for US Depression Drugs Market
7.2 Market Opportunities & Trends
7.3 Market Drivers
7.4 Market Restraints

8 Conclusion

9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Key Players of Depression Drugs in US
Table 2. Top Players in US, Ranking by Revenue (2019)
Table 3. US Depression Drugs Revenue by Companies, (US$, Mn), 2015-2020
Table 4. US Depression Drugs Revenue Share by Companies, 2015-2020
Table 5. US Depression Drugs Sales by Companies, (K Units), 2015-2020
Table 6. US Depression Drugs Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Depression Drugs Price (2015-2020) (US$/Unit)
Table 8. US Manufacturers Depression Drugs Product Type
Table 9. List of US Tier 1 Depression Drugs Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of US Tier 2 and Tier 3 Depression Drugs Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Depression Drugs Revenue in US (US$, Mn), 2015-2020
Table 12. By Type - Depression Drugs Revenue in US (US$, Mn), 2021-2026
Table 13. By Type - Depression Drugs Sales in US (K Units), 2015-2020
Table 14. By Type - Depression Drugs Sales in US (K Units), 2021-2026
Table 15. By Application - Depression Drugs Revenue in US, (US$, Mn), 2015-2020
Table 16. By Application - Depression Drugs Revenue in US, (US$, Mn), 2021-2026
Table 17. By Application - Depression Drugs Sales in US, (K Units), 2015-2020
Table 18. By Application - Depression Drugs Sales in US, (K Units), 2021-2026
Table 19. Intellipharmaceutics Corporate Summary
Table 20. Intellipharmaceutics Depression Drugs Product Offerings
Table 21. Intellipharmaceutics Depression Drugs Revenue (US$, Mn), (2015-2020)
Table 22. Pfizer Corporate Summary
Table 23. Pfizer Depression Drugs Product Offerings
Table 24. Pfizer Depression Drugs Revenue (US$, Mn), (2015-2020)
Table 25. Eli Lilly Corporate Summary
Table 26. Eli Lilly Depression Drugs Product Offerings
Table 27. Eli Lilly Depression Drugs Revenue (US$, Mn), (2015-2020)
Table 28. Astrazeneca Corporate Summary
Table 29. Astrazeneca Depression Drugs Product Offerings
Table 30. Astrazeneca Depression Drugs Revenue (US$, Mn), (2015-2020)
Table 31. Lundbeck Corporate Summary
Table 32. Lundbeck Depression Drugs Product Offerings
Table 33. Lundbeck Depression Drugs Revenue (US$, Mn), (2015-2020)
Table 34. Allergan Corporate Summary
Table 35. Allergan Depression Drugs Product Offerings
Table 36. Allergan Depression Drugs Revenue (US$, Mn), (2015-2020)
Table 37. GSK Corporate Summary
Table 38. GSK Depression Drugs Product Offerings
Table 39. GSK Depression Drugs Revenue (US$, Mn), (2015-2020)
Table 40. Otsuka Pharmaceutical Corporate Summary
Table 41. Otsuka Pharmaceutical Depression Drugs Product Offerings
Table 42. Otsuka Pharmaceutical Depression Drugs Revenue (US$, Mn), (2015-2020)
Table 43. Takeda Corporate Summary
Table 44. Takeda Depression Drugs Product Offerings
Table 45. Takeda Depression Drugs Revenue (US$, Mn), (2015-2020)
Table 46. NHU Group Corporate Summary
Table 47. NHU Group Depression Drugs Product Offerings
Table 48. NHU Group Depression Drugs Revenue (US$, Mn), (2015-2020)
Table 49. Shionogi Corporate Summary
Table 50. Shionogi Depression Drugs Product Offerings
Table 51. Shionogi Depression Drugs Revenue (US$, Mn), (2015-2020)
Table 52. APOTEX Corporate Summary
Table 53. APOTEX Depression Drugs Product Offerings
Table 54. APOTEX Depression Drugs Revenue (US$, Mn), (2015-2020)
Table 55. Kanghong Pharma Corporate Summary
Table 56. Kanghong Pharma Depression Drugs Product Offerings
Table 57. Kanghong Pharma Depression Drugs Revenue (US$, Mn), (2015-2020)
Table 58. HUAHAI Corporate Summary
Table 59. HUAHAI Depression Drugs Product Offerings
Table 60. HUAHAI Depression Drugs Revenue (US$, Mn), (2015-2020)
List of Figures
Figure 1. Depression Drugs Segment by Type
Figure 2. Depression Drugs Segment by Application
Figure 3. US Depression Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Depression Drugs Market Size in US, (US$, Mn): 2020 VS 2026
Figure 6. US Depression Drugs Revenue, 2015-2026 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Depression Drugs Revenue in 2019
Figure 8. By Type - US Depression Drugs Incremental Growth, (US$, Mn), 2015-2026
Figure 9. By Type - US Depression Drugs Market Share, 2015-2026
Figure 10. By Application - Depression Drugs Revenue in US (US$, Mn), 2020 & 2026
Figure 11. By Application - US Depression Drugs Market Share, 2015-2026
Figure 12. PEST Analysis for US Depression Drugs Market in 2020
Figure 13. Depression Drugs Market Opportunities & Trends in US
Figure 14. Depression Drugs Market Drivers in US
  • Global Divalproex Sodium Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026
    Published: 08-Jul-2020        Price: US 5900 Onwards        Pages: 114
    Divalproex Sodium market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Divalproex Sodium market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026. Segment by Type, the Divalproex Sodium market ......
  • 2015-2025 Global Codeine Market Research by Type, End-Use and Region (COVID-19)
    Published: 05-Jul-2020        Price: US 2900 Onwards        Pages: 132
    Summary The global Codeine market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025. Further key aspects of the report indicate that: Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size Chapter 2: Global Production & Consumption Market by Type and End-Use Chapter 3: Europe Production & Consumption Market by Type and End-Use Chapter 4: America Production & Consumption Marke......
  • COVID-19 Outbreak-Global Adhd Drugs Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
    Published: 30-Jun-2020        Price: US 3660 Onwards        Pages: 128
    The Adhd Drugs market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry......
  • COVID-19 Outbreak-Global Clozapine Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
    Published: 23-Jun-2020        Price: US 3660 Onwards        Pages: 113
    The Clozapine market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry developm......
  • Global Trazodone Hydrochloride (API) Market Research Report 2020 (Covid-19 Version)
    Published: 21-Jun-2020        Price: US 3500 Onwards        Pages: 135
    Summary Market Segment as follows: By Region - Asia-Pacific - North America - Europe - South America - Middle East & Africa By Type - Tablet - Capsule By Application - Antidepression - Anxiolytic - Hypnotic - Others By Company - Teva - Angelini - Mylan - Fermion - The Piramal Group The main contents of the report......
  • Codeine Market Research: Global Status & Forecast by Geography, Type & Application (2016-2026)
    Published: 20-Jun-2020        Price: US 2280 Onwards        Pages: 67
    Summary According to 99Strategy, the Global Codeine Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during the 2021-2026. The report analyses the global Codeine market, the market size and growth, as well as the major market participants. The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driv......
  • COVID-19 Impact on Global Alprazolam Market Insights, Forecast to 2026
    Published: 19-Jun-2020        Price: US 3900 Onwards        Pages: 116
    Alprazolam market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alprazolam market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Alprazolam market is segmented into - 250 Microgram/Piece - 500 Microgram/Piece Segment by Applicat......
  • COVID-19 Impact on Global Bipolar Disorder Therapeutics Drugs Market Insights, Forecast to 2026
    Published: 16-Jun-2020        Price: US 4900 Onwards        Pages: 154
    Bipolar Disorder Therapeutics Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bipolar Disorder Therapeutics Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Bipolar Disorder Therapeutics Drugs market is segmented into......
  • Global Alprazolam Market Insights, Forecast to 2026
    Published: 12-Jun-2020        Price: US 3900 Onwards        Pages: 110
    Alprazolam market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alprazolam market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Alprazolam market is segmented into - 250 Microgram/Piece - 500 Microgram/Piece Segment by Applicat......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs